SMIadviser.org will not be accessible after 11:59pm ET on July 8, 2024. Thank you for your support over the past six years!

An APA and SAMHSA Initiative

Clinicians
Individuals & Families
Our Tools
About Us
Calendar
Contact

Find The Answers You Need In Our Knowledge Base

Search topics, find resources, and enhance what you know about SMI.

/ Knowledge Base (Clinicians)

Clinicians Knowledge Base

If you’re looking for the Individuals & Families Knowledge Base, click here

Searching..

assisted outpatient treatmentclozapine blood levelsco morbid medical conditionscovid 19manualized psychotherapiespeer specialistspsychopharmacologyspecial populationsclinician handouts for patients and familiesclozapine as part of the treatment planfamily involvement and engagementself-management of symptoms of SMIsuicide prevention and crisis management

Showing All Results

Sort

Most Recent Most Relevant A-Z Z-A

Bookmarked

Bookmarked Posts Will Appear Here

Filter by Year

20192024

Categories

Assisted outpatient treatmentCOVID-19Clinical high riskClinician handouts for patients and familiesClozapineCo-morbid medical conditionsCo-morbid substance use disordersCollaborative care / Integrated care modelsEditor’s Choice CollectionsFamily involvement / EngagementForensicsInformación en EspañolManualized psychotherapiesMood disorderPTSDPeer specialistsPsychopharmacologyRural and remote settingsSMI 101SMI in special populationsSchizophreniaSelf-management of symptomsService deliverySuicide prevention and crisis managementSystems issuesTechnology in treatment

Tags

AdoptionAdvance DirectiveAdvocacyAlternative Payment Models Standards (APMS)Alternatives to HospitalizationAppsAssertive Community Treatment (ACT)Assisted Outpatient Treatment (AOT)Biomarkers and GeneticsBipolarBrief Interpersonal Therapy (BIT)COVID-19Civil CommitmentClinical High RiskClozapineCo-morbid Medical ConditionsCognitive Behavioral Therapy (CBT)Cognitive Remediation Therapy (CRT)Complementary Approaches (CAM)Coordinated Specialty Care (CSC)Crisis Intervention Training (CIT)Crisis ManagementCultural CompetencyDepressionDialectic Behavioral Therapy (DBT)Drug CourtsElectronic Medical RecordsExposureExposure and Response Prevention (ERP)Family InvolvementFederalFinancingFirst Break PsychosisGuidelinesHealth NavigatorHealth SystemHigh UtilizersHomelessHousing FirstImplementationInpatient CareIntegrated CareIntellectual Development Disorders (IDD)Interpersonal Therapy with Depression (IPT)Jail DiversionLGBTQLevel of CareLocalLong-acting InjectablesManualized Psychotherapy (General)Medication-Assisted Treatment (MAT)Mental Health CourtsMinority and Under-represented GroupsMotivational Interviewing (MI)Multisystemic Therapy (MST)Network AdequacyNeuromodulationOlder AdultsOpen DialogueOutreachPTSDPeer EngagementPeer NavigatorsPeer-led InterventionsPolicyPracticePregnancyProblem-Solving Therapy (PST)PsychopharmacologyRe-entry ProgramsResearch StudiesRestraint and SeclusionRisk FactorsRural and Remote SettingsSMI 101SchizophreniaScreeningSelf-managementSequential InterceptShared Decision MakingSocial Rhythm Therapy (SRT)StateStigmaSubstance Use DisordersSuicide PreventionSuicide Risk AssessmentSupport of FamiliesSupported EducationSupported EmploymentSupportive HousingTelemedicineTobaccoTransitional Age YouthTrauma-Informed CareTreatment Resistant DisordersUnderserved PopulationsVeteransViolence Risk AssessmentWellnessWomenWorkforceWraparound Servicespati

Authors

Alan Tomás Rodríguez PenneyAlexander S. YoungAlexandra SosnowskiAlexia PolilloAlexia WolfAmy N. CohenAndrew CarloAnne SpinaAyana JordanBenjamin DrussBradleigh DornfeldBrandon NeisewanderBrent J. GibbonsCarrie CunninghamCharles L. ScottDana FoglesongDebra A. PinalsDonna RolinElie AounHéctor Colon-RiveraJohn TorousJonathan MeyerJoseph VenturaJosé M. ViruetKelly DavisKenneth MinkoffKunmi SobowaleLilanthi BalasuriyaLisa B. DixonMark S. BauerMatthew L. GoldmanMegan EhretMichael A. ZingmanMiranda G. GreinerMisty RichardsNicole KozloffOliver FreudenreichPatrick HendryRachel RobitzRishi SawhneyRobert O. CotesSMI Adviser Clinical Expert TeamSMI Adviser Clozapine WorkgroupSMI Adviser LAI WorkgroupShea JorgensenSherin KhanStephanie A. RolinTeri BristerTimothy Fong

Clozapine & LAI Virtual Forum – June 2024 (Video) – Therapeutic Drug Monitoring (TDM) for Antipsychotic Medications

Answered by:

SMI Adviser LAI Workgroup

Date Answered: June 6, 2024

Publisher: SMI Adviser

Share

Share on Facebook Share on Twitter Share on LinkedIn Share via Email

How can I learn more about person first language when speaking with someone with psychosis, their family or my colleagues?

Answered by:

Teri Brister, PhD, LPC, SMI Patient and Family Engagement Expert - National Alliance on Mental Illness

Date Answered: May 30, 2024

Publisher: NAMI

Share

Share on Facebook Share on Twitter Share on LinkedIn Share via Email

Maximizing Treatment Outcomes with Lithium: A Video Series for Healthcare Professionals

Answered by:

Date Answered: May 14, 2024

Publisher: SMI Adviser

Share

Share on Facebook Share on Twitter Share on LinkedIn Share via Email

Rendering Safe and Therapeutic De-escalation Interventions

Publisher: SMI Adviser

Year of Publication: 2024

Share

Share on Facebook Share on Twitter Share on LinkedIn Share via Email

How do I prescribe lithium?

Answered by:

Date Answered: April 22, 2024

Publisher: SMI Adviser

Share

Share on Facebook Share on Twitter Share on LinkedIn Share via Email

Critical Components for Understanding Veterans with Serious Mental Illness

Publisher: SMI Adviser

Year of Publication: 2024

Share

Share on Facebook Share on Twitter Share on LinkedIn Share via Email

Clozapine & LAI Virtual Forum – April 2024 (Video) – LAIs and VMAT2 Inhibitors

Answered by:

SMI Adviser LAI Workgroup

Date Answered: April 3, 2024

Publisher: SMI Adviser

Share

Share on Facebook Share on Twitter Share on LinkedIn Share via Email

Creating an Optimal Work Environment For Clinicians Caring for Individuals with SMI

Date Answered: March 25, 2024

Publisher: SMI Adviser

Share

Share on Facebook Share on Twitter Share on LinkedIn Share via Email

Providing Care After Release from a Carceral Setting to Individuals with SMI (Videos)

Date Answered: March 21, 2024

Publisher: SMI Adviser

Share

Share on Facebook Share on Twitter Share on LinkedIn Share via Email

What should clinicians know about Sublocade (Suboxone)?

Answered by:

SMI Adviser LAI Workgroup

Date Answered: March 11, 2024

Share

Share on Facebook Share on Twitter Share on LinkedIn Share via Email

What should clinicians know about Vivitrol (Naltrexone)?

Answered by:

SMI Adviser LAI Workgroup

Date Answered: March 11, 2024

Share

Share on Facebook Share on Twitter Share on LinkedIn Share via Email

What should clinicians know about Brixadi (Subutex)?

Answered by:

SMI Adviser LAI Workgroup

Date Answered: March 11, 2024

Share

Share on Facebook Share on Twitter Share on LinkedIn Share via Email

Clozapine & LAI Virtual Forum – March 2024 (Video) – Debating the Use of Clozapine with Fluvoxamine

Answered by:

SMI Adviser Clozapine Workgroup

Date Answered: March 7, 2024

Publisher: SMI Adviser

Share

Share on Facebook Share on Twitter Share on LinkedIn Share via Email

The Roles of Forensic Social Work in Caring for Individuals with Serious Mental Illness

Publisher: SMI Adviser

Year of Publication: 2024

Share

Share on Facebook Share on Twitter Share on LinkedIn Share via Email

Clozapine & LAI Virtual Forum – February 2024 (Video) – Comparing Aripiprazole LAI Products

Answered by:

SMI Adviser LAI Workgroup

Date Answered: February 7, 2024

Publisher: SMI Adviser

Share

Share on Facebook Share on Twitter Share on LinkedIn Share via Email

Join our #MissionForBetter now

Sign up for our newsletter. We’ll let you know about new resources, education, and more.

Administered by

Funded by

About SMI Adviser

Mission Statement
Our mission is to advance the use of a person-centered approach to care that ensures people who have SMI find the treatment and support they need. For clinicians, we offer access to education, data, and consultations so you can make evidence-based treatment decisions. For patients, families, friends, people who have questions, or people who care for someone with SMI, we offer access to resources and answers from a national network of experts.
Grant Statement
Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.
Terms & Privacy
Copyright

Sitemap

Clinicians
About Us
Contact

SMI Adviser is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of the website's resources, please call us at 202-559-3900 for assistance.

Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.

© 2025 American Psychiatric Association. All rights reserved.

(Esc)